Clinical Trial Update: NK Activity Modulation Induced by Intravenous Lidocaine During Colorectal Laparoscopic Surgery [Phase 4]

View source ↗

Summary

This clinical trial update outlines a Phase 4 study evaluating whether intravenous lidocaine modulates natural killer cell activity in colorectal cancer patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: Maisonneuve-Rosemont Hospital | Conditions: Colorectal Cancer | Phase 4 | Status: UNKNOWN